Company intelligence / Profile preview

Beyond Seeds

Florida, United Statesbeyond-seeds.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Beyond Seeds develops technological innovations in plant biotechnology with applications spanning the agri-food industry and health sector. The group comprises six companies offering products/services such as seed phenotyping/genotyping systems, precision agriculture inputs, nutraceuticals, nanotechnology solutions for crop improvement and potentially cancer research. There are no disclosed clinical results for human therapeutic programs.

Therapeutic areas: Oncology
Modalities: Plant biotechnology products and servicesNanotechnology applicationsNutraceuticalsIn vitro cultivation technologiesPrecision fertilizers and microorganisms for plant health/agriculture
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Beyond Seeds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beyond Seeds.

Explore the full profile